全、新、优、品、好四大特点：

间变性激酶核相互作用伴侣蛋白抗体规格 全：公司提供上万种产品，涵盖了生物试剂，elisa试剂盒，标准品，培养基，原装耗材，抗体、培养基、ATCC细胞等，基本上各种科研所需产品在我司都能找到。

新：产品更新速度较快，基本上每周都有新产品出现。

优：产品质量好，投诉比较少。

好：我公司具有优质的技术团队，产品一旦售出，实验过程中遇到困难可提供在线技术咨询。使您使用产品时没有任何的后顾之忧。

间变性激酶核相互作用伴侣蛋白抗体规格 英文名称  Anti-NIPA

中文名称  间变性激酶核相互作用伴侣蛋白抗体规格 

别    名 hNIPA; Nuclear interacting partner of ALK; Nuclear interacting partner of anaplastic lymphoma kinase; ZC3HC1; Zinc finger C3HC type containing 1; NIPA_HUMAN.

产品属性：

浓    度  1mg/1ml

规 格  0.2ml/200μg

抗体来源  Rabbit

克隆类型   polyclonal

交叉反应   Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep

产品类型   一抗  

研究领域     细胞生物 免疫学 染色质和核信号 信号转导 激酶和磷酸酶

蛋白分子量  predicted molecular weight: 55kDa 

性    状   Lyophilized or Liquid

免 疫 原  KLH conjugated synthetic peptide derived from human NIPA

亚    型  IgG

纯化方法   affinity purified by Protein A

储 存 液   Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

间变性激酶核相互作用伴侣蛋白抗体规格 产品应用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200

（石蜡切片需做抗原修复） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存条件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

产品介绍 The regulated oscillation of protein expression is an essential mechanism of cell cycle control. The SCF class of E3 ubiquitin ligases is involved in this process by targeting cell cycle regulatory proteins for degradation by the proteasome, with the F-box subunit of the SCF specifically recruiting a given substrate to the SCF core. NIPA (nuclear interaction partner of ALK) is a human F-box-containing protein that defines an SCF-type E3 ligase (SCFNIPA) controlling mitotic entry. Assembly of this SCF complex is regulated by cell-cycle-dependent phosphorylation of NIPA, which restricts substrate ubiquitination activity to interphase. Nuclear cyclin B1 is a substrate of SCFNIPA. Inactivation of NIPA by RNAi results in nuclear accumulation of cyclin B1 in interphase, activation of cyclin B1-Cdk1 kinase activity, and premature mitotic entry. Thus, SCFNIPA-based ubiquitination may regulate S-phase completion and mitotic entry in the mammalian cell cycle.

Function : Essential component of an SCF-type E3 ligase complex, SCF(NIPA), a complex that controls mitotic entry by mediating ubiquitination and subsequent degradation of cyclin B1 (CCNB1). Its cell-cycle-dependent phosphorylation regulates the assembly of the SCF(NIPA) complex, restricting CCNB1 ubiquitination activity to interphase. Its inactivation results in nuclear accumulation of CCNB1 in interphase and premature mitotic entry. May have an antiapoptotic role in NPM-ALK-mediated signaling events.Subunit : Interacts with the NPM-ALK fusion protein in a tyrosine phosphorylation-dependent manner. Interacts with SKP1. Component of a SCF(NIPA) E3 complex with SKP1, RBX1 and CUL1 when not phosphorylated on Ser-354. Interacts with CCNB1.Subcellular Location : NuclearTissue Specificity : Widely expressed. Highly expressed in heart, skeletal muscle and testis. Expressed in brain, placenta, lung, kidney, liver, pancreas, spleen, thymus, prostate, ovary small intestine and colon. Weakly or not expressed in leukocytes.Post-translational modifications : Phosphorylated. Phosphorylated on Ser residues at G2/M phase, but not during S and G0 phases. May also be weakly phosphorylated on Tyr residues. Ser-354 phosphorylation, a major site during the course of cell-cycle-dedendent phosphorylation, results in its dissociation from the SCF(NIPA) complex, thereby preventing CCNB1 degradation leading to mitotic entry.Similarity : Contains 1 C3HC-type zinc finger.Database links : UniProtKB/Swiss-Prot: Q86WB0.1

实验流程：

正在热销的相关产品：

ACA(Human adrenal cortex antibody) ELISA Kit 人肾上腺皮质抗体Multi-class antibodies规格： 48T

Anti-MK6 原活化蛋白激酶MKK6抗体Multi-class antibodies规格： 0.2ml

Rhesus antibody Rh HSPB2 热休克蛋白B2抗体 规格 0.1ml

IgG ELISA Kit 大鼠免疫球蛋白G 96T

Pet1 英文名称： ETS结构域转录因子FEV抗体 0.2ml

CABLES1 英文名称： 细胞周期蛋白依赖性激酶CABLES1抗体 0.2ml

Anti-MK6 原活化蛋白激酶MKK6抗体Multi-class antibodies规格： 0.2ml

(Mouse anti-IVIgG antibody) ELISA Kit 小鼠抗IVIgG抗体Multi-class antibodies规格： 48T

Anti-CD82/KAI1/FITC 荧光素标记转移抑制蛋白1抗体IgGMulti-class antibodies规格： 0.2ml

Rhesus antibody Rh DP1/TFDP1 转录因子DP1抗体 规格 0.1ml

CA125 相关抗原 96T

MGLUR1 + MGLUR5 英文名称： 促代谢型谷酸受体1+5抗体 0.2ml

ALDH16A1 英文名称： 乙醛脱氢酶16家庭A1抗体 0.2ml

Anti-CD82/KAI1/FITC 荧光素标记转移抑制蛋白1抗体IgGMulti-class antibodies规格： 0.2ml

Ifi205(Human interferon activated gene 205) ELISA Kit 人干扰素活化基因205Multi-class antibodies规格： 48T

Anti-PAX3 配对盒基因3抗体Multi-class antibodies规格： 0.2ml

Rhesus antibody Rh HOPX/LAGY 相关蛋白Y抗体 规格 0.2ml

SOD(Mouse Super Oxidase Dimutase)ELISA Kit 小鼠超氧化物歧化酶 96T

PTHLH 英文名称： 甲状旁腺激素相关蛋白抗体 0.1ml

CDC40 英文名称： 细胞分裂周期同源蛋白40抗体 0.2ml

Anti-PAX3 配对盒基因3抗体Multi-class antibodies规格： 0.2ml

GlucoseAsparagineMedium

DMEM(低糖)，干粉 "含1000mg/l葡萄糖，L-谷氨酰胺， incubation media DMEM(低糖)，干粉 "含1000mg/l葡萄糖，L-谷氨酰胺，

酵米面假单胞菌(酵米面黄杆菌) 支/瓶

CIN-(9cm)用于分离小肠耶尔森氏菌

RVSalmonellaEnrichmentMedium

抗生素检定培养基H)(05药典)250g用于磺苄青霉素效价测定

马铃薯琼脂 100(g) incubation media 马铃薯琼脂 100(g)

磷酸盐葡萄糖蛋白胨水培养基 Phosphate Glucose Peptone Water 250克 用于甲基红试验

菌种培养基250用于四环素检定中蜡样芽孢杆菌的培养(SN标准)incubationmedia菌种培养基250用于四环素检定中蜡样芽孢杆菌的培养(SN标准)

我妻氏培养基基础 250g 用于副溶血性弧菌神奈川现象试验(GB标准、SN)

间变性激酶核相互作用伴侣蛋白抗体规格 亮绿乳糖液体培养基（BGB）  规格：  250g  用途：  用于多管发酵法测定饮用矿泉水中大肠菌群的确证试验(GB/T8538-2008)。

品红亚培养基（远藤琼脂培养基）  规格：  250g  用途：  用于水中大肠菌群的分离或确证试验。 (GB/T8538-2008和GB5750.12—2006)。

乳糖胆盐发酵培养基  规格：  250g  用途：  用于多管发酵法测定食品、药品、纯净水、矿泉水和一次性使用卫生用品中大肠菌群、粪大肠菌群和大...

大肠菌群显色培养基  规格：  1000ml  用途：  用于大肠菌群的快速检测和计数。

技术外包服务:

★间变性激酶核相互作用伴侣蛋白抗体规格 分子生物学：质粒抽提、PCR、Q-PCR、RT-PCR、分子生物学：基因合成、引物合成、基因测序、载体构建等

★蛋白工程：原核、哺乳动物蛋白表达系统等

★病毒包装：腺病毒、慢病毒等

★抗体工程：磁珠分选、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★细胞工程：细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。